D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine

Shun-ichi KimuraDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Hidenori WadaDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Yuko IshiharaDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Koji KawamuraDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Kana SakamotoDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Ryoko YamasakiDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Masahiro AshizawaDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Tomohito MachishimaDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Miki SatoDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Kiriko TerasakoDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Hideki NakasoneDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Misato KikuchiDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Shinya OkudaDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Shinichi KakoDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Junya KandaDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Rie YamazakiDivision of HematologySaitama Medical Center, Jichi Medical University, Japan

Articles from other publishers (9)